Reacción #44175

Ecuación de reacción

1,1-dimethylethyl 2-{[(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)amino]methyl}-1-pyrrolidinecarboxylate

hydrogen chloride

triphosgene

diisopropylamine

→

title compound

(R)-2-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)hexahydro-3H-pyrrolo[1,2-c]imidazol-3-one

Disolventes

methanol

ether

Condiciones de reacción

Tratamiento posterior

1. 1
   Concentraciónthen concentrated under vacuum
2. 2
   Lavadoeluted with methanol
3. 3
   ConcentraciónThe combined basic fractions were concentrated under vacuum
4. 4
   workup.DISSOLUTIONThe residue, (10 mg) was then dissolved in DCM (1 mL)
5. 5
   workup.STIRRINGThe mixture was stirred for 1 h
6. 6
   Concentraciónthen concentrated under vacuum
7. 7
   Otropurified by preparative mass-directed hplc

Procedimiento

A solution of (R)-(1,1-dimethylethyl 2-{[(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)amino]methyl}-1-pyrrolidinecarboxylate in methanol was treated with a solution of hydrogen chloride in ether (1M). The resulting mixture was stirred 30 minutes then concentrated under vacuum and then loaded onto an ion-exchange cartridge (SCX-2) and eluted with methanol followed by ammonia in methanol (1 M). The combined basic fractions were concentrated under vacuum. The residue, (10 mg) was then dissolved in DCM (1 mL) and treated with triphosgene (23 mg, 0.3 eq.), diisopropylamine (4 uL, 3 eq.). The mixture was stirred for 1 h then concentrated under vacuum and purified by preparative mass-directed hplc to afford the title compound (3.1 mg).

Fuente